enGene Therapeutics Inc. (ENGN): 10-Q filed Jun 15, 2026

Form type

10-Q

Filing date

Jun 15, 2026

Accession number

0001193125-26-270386

Filer

enGene Therapeutics Inc. (CIK 1980845)